Adlai Nortye (NASDAQ:ANL) Shares Up 3.9% – What’s Next?

Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL)’s stock price traded up 3.9% during trading on Thursday . The company traded as high as $15.56 and last traded at $15.26. Approximately 11,246 shares traded hands during trading, a decline of 97% from the average daily volume of 383,925 shares. The stock had previously closed at $14.69.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on ANL shares. Oppenheimer began coverage on Adlai Nortye in a research note on Thursday, May 28th. They issued an “outperform” rating and a $32.00 price objective for the company. Wall Street Zen cut Adlai Nortye from a “buy” rating to a “hold” rating in a research report on Saturday. HC Wainwright reissued a “buy” rating and set a $20.00 target price on shares of Adlai Nortye in a research note on Tuesday. Loop Capital set a $49.00 price target on Adlai Nortye in a report on Tuesday. Finally, Jefferies Financial Group started coverage on Adlai Nortye in a research note on Thursday. They issued a “buy” rating and a $31.00 price target for the company. Six equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $29.50.

Adlai Nortye Stock Up 0.8%

The company has a current ratio of 9.55, a quick ratio of 0.65 and a debt-to-equity ratio of 0.04. The stock has a 50-day moving average price of $13.01 and a two-hundred day moving average price of $11.56.

Insiders Place Their Bets

In other Adlai Nortye news, CFO Xiaofeng Ye sold 6,000 shares of the firm’s stock in a transaction that occurred on Monday, August 24th. The stock was sold at an average price of $13.98, for a total transaction of $83,880.00. Following the completion of the transaction, the chief financial officer owned 153,424 shares in the company, valued at $2,144,867.52. This trade represents a 3.76% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of ANL. SmartHarvest Portfolios LLC increased its position in Adlai Nortye by 8.5% in the first quarter. SmartHarvest Portfolios LLC now owns 16,367 shares of the company’s stock worth $113,000 after purchasing an additional 1,279 shares during the last quarter. Renaissance Technologies LLC bought a new position in Adlai Nortye during the first quarter valued at $457,000. ADAR1 Capital Management LLC purchased a new position in shares of Adlai Nortye in the 1st quarter worth $816,000. Affinity Asset Advisors LLC purchased a new position in shares of Adlai Nortye in the 1st quarter worth $1,140,000. Finally, Seven Fleet Capital Management LP bought a new stake in shares of Adlai Nortye in the 2nd quarter worth about $1,302,000. 35.21% of the stock is currently owned by institutional investors.

Adlai Nortye Company Profile

Adlai Nortye Inc (NASDAQ: ANL) is a specialty chemical manufacturer headquartered in China’s Jiangsu Province. The company focuses on the research, development, production and sale of fine chemicals, with a primary emphasis on amino acids and their derivatives.

Adlai Nortye’s product portfolio includes betaine compounds, a range of high-purity L-amino acids such as L-methionine, L-threonine and glycine, as well as various chemical intermediates. These offerings serve multiple end markets, including animal feed and nutrition, personal care and cosmetic formulations, pharmaceutical ingredients and industrial chemical processes.

The company operates multiple production facilities alongside an in-house research and development center dedicated to process innovation and quality control.